NVCT
Nuvectis Pharma, Inc.
Pharmaceutical PreparationsNasdaq<br>Emerging growth company
Total Trades
86
Buys
84
Sells
1
Largest Trade
N/A
Insiders
8
Institutional Funds
39
Inst. Value
$1M+
Activist Filings
11
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 2K | $10.86 | Mar 16, 2023 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 500 | $7.65 | Dec 22, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 150 | $7.45 | Nov 30, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 450 | $7.41 | Nov 29, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 750 | $7.23 | Nov 21, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 300 | $7.15 | Nov 18, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 1K | $7.07 | Nov 16, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 1K | $7.34 | Oct 3, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 220 | $7.87 | Sep 27, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 2K | $7.85 | Sep 27, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 2K | $8.29 | Sep 6, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 404 | $8.31 | Sep 6, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $15K–$50K | 3K | $8.07 | Sep 2, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 2K | $9.05 | Aug 30, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $100K–$500K | 19K | $8.69 | Aug 22, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $100K–$500K | 20K | $8.40 | Aug 16, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 4K | $11.63 | Jun 30, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1K–$15K | 700 | $12.09 | Jun 27, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 1K | $15.82 | May 31, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 1K | $16.73 | May 23, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 300 | $16.54 | May 23, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 2K | $19.48 | May 19, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $1K–$15K | 242 | $19.44 | May 18, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 2K | $18.82 | May 17, 2022 |
| Hoberman Kenneth | Director | BUY | $100K–$500K | 6K | $17.40 | May 16, 2022 |
| Kaplan Matthew L. | Director | BUY | $50K–$100K | 3K | $16.88 | May 16, 2022 |
| Poradosu Enrique | Chief Science & Bu… | BUY | $1K–$15K | 670 | $15.33 | May 16, 2022 |
| Shemesh Shay | Chief Dev. & Ops. … | BUY | $15K–$50K | 1K | $15.85 | May 13, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $100K–$500K | 12K | $16.99 | May 13, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 4K | $7.05 | Mar 29, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $50K–$100K | 7K | $7.63 | Mar 18, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $15K–$50K | 8K | $5.88 | Feb 15, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $50K–$100K | 9K | $6.34 | Feb 11, 2022 |
| Poradosu Enrique | Chief Science & Bu… | BUY | $15K–$50K | 5K | $3.44 | Feb 8, 2022 |
| Shemesh Shay | Chief Development … | BUY | $1K–$15K | 3K | $3.41 | Feb 8, 2022 |
| BENTSUR RON | Chairman & CEO | BUY | $1M+ | 233K | $4.96 | Feb 8, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 39 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| IRIDIAN ASSET MANAGEMENT LLC/CT | 536K | $1M+ | SH |
| BALDWIN WEALTH PARTNERS LLC/MA | 390K | $1M+ | SH |
| Occam Crest Management LP | 380K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 312K | $1M+ | SH |
| STATE STREET CORP | 155K | $1M+ | SH |
| OPPENHEIMER & CO INC | 74K | $500K+ | SH |
| FORBES J M & CO LLP | 59K | $100K–$500K | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 44K | $100K–$500K | SH |
| BARCLAYS PLC | 24K | $100K–$500K | SH |
| Austin Wealth Management, LLC | 20K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 18K | $100K–$500K | SH (Call) |
| Nuveen, LLC | 17K | $100K–$500K | SH |
| GOLDMAN SACHS GROUP INC | 15K | $100K–$500K | SH |
| CIBC Private Wealth Group LLC | 15K | $100K–$500K | SH |
| Avalon Trust Co | 14K | $100K–$500K | SH |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 13K | $50K–$100K | SH |
| RHUMBLINE ADVISERS | 8K | $50K–$100K | SH |
| UBS Group AG | 8K | $50K–$100K | SH |
| Bank of New York Mellon Corp | 8K | $50K–$100K | SH |
| VANGUARD GROUP INC | 6K | $15K–$50K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Nov 5, 2024
1.5%
289K shares
SC 13G/A · Feb 28, 2024
15.0%
2.6M shares
SC 13G/A · Feb 1, 2024
8.7%
1.5M shares
SC 13G/A · Feb 1, 2024
8.6%
1.5M shares
SC 13G/A · Jan 31, 2024
5.2%
908K shares
SC 13G · Apr 3, 2023
6.4%
948K shares
SC 13G · Feb 13, 2023
8.2%
1.2M shares
SC 13G · Feb 13, 2023
8.3%
1.2M shares
SC 13G/A · Jan 9, 2023
16.3%
2.4M shares
SC 13G/A · Mar 28, 2022
11.0%
1.4M shares
SC 13D · Mar 28, 2022
21.5%
2.7M shares